Sony, Olympus JV Delayed By Months Awaiting China Antitrust Clearance
This article was originally published in PharmAsia News
The planned medical-device joint venture of Sony and Olympus apparently is to be pushed into next year, in part because of increased political tensions between Japan and China.
You may also be interested in...
The combination of bupivacaine and meloxicam will be priced at a discount to Exparel, with Heron predicting rapid uptake. Label limited to three surgery types, but analysts expect off-label use.
Increasing number of product development meetings suggests that many complex generics remain in the development stages.
An expert panel at the recent AdvaMed Virtual Digital MedTech Conference discusses opportunities for medtech and consumer tech collaborations and how to make them successful.